Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04553770
Title Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

breast carcinoma

Therapies

Trastuzumab deruxtecan

Anastrozole + Trastuzumab deruxtecan

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
St. Joseph Heritage Healthcare Recruiting Fullerton California 92835 United States Details
Cancer Blood and Specialty Clinic Recruiting Los Alamitos California 90720 United States Details
UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles California 90095 United States Details
Torrance Memorial Physician Network / Cancer Care Recruiting Torrance California 90602 United States Details
PIH Health Recruiting Whittier California 90602 United States Details
Orlando Health, Inc. d/b/a Orlando Health UF Health Center Recruiting Orlando Florida 32806 United States Details
Ft. Wayne Medical Oncology and Hematology, Inc. Recruiting Fort Wayne Indiana 46804 United States Details
Cancer Center of Kansas Recruiting Wichita Kansas 67214 United States Details
Massachusetts General Hospital Not yet recruiting Boston Massachusetts 02114 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field